Literature DB >> 20651017

Parasellar T2 dark sign on MR imaging in patients with lymphocytic hypophysitis.

Y Nakata1, N Sato, T Masumoto, H Mori, H Akai, H Nobusawa, Y Adachi, H Oba, K Ohtomo.   

Abstract

BACKGROUND AND
PURPOSE: MR imaging findings of LYH and pituitary adenomas are similar, but the therapeutic strategies are completely different. The purpose of this study was to evaluate sellar and parasellar MR imaging findings in patients with both diseases, as well as characteristic clinical findings.
MATERIALS AND METHODS: Clinical findings, including endocrinologic study and MR images of 20 patients with LYH and 22 patients with pituitary adenoma, were retrospectively reviewed. We evaluated the MR images in relation to the following: 1) the PPHI on T1-weighted images, 2) thickened stalk (>3.5 mm), 3) pituitary symmetry, 4) pituitary enhancement pattern, 5) a dural tail, and 6) parasellar signal intensity on T2- and T1-weighted images.
RESULTS: Between patients with LYH and those with pituitary adenoma, a significant difference was identified for the number of patients with loss of PPHI, thickened stalk, pituitary symmetry, homogeneous enhancement, and parasellar dark signal intensity on T2-weighted images by statistical analysis (Fisher exact probability test, P < .05). Among them, only parasellar dark signal intensity on T2-weighted images had no false-positive cases.
CONCLUSIONS: The parasellar T2 dark sign can be a specific finding used to distinguish pituitary adenoma from LYH.

Entities:  

Mesh:

Year:  2010        PMID: 20651017      PMCID: PMC7964016          DOI: 10.3174/ajnr.A2201

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  48 in total

1.  Inflammatory hypophysitis - the spectrum of disease.

Authors:  D E H Flanagan; A E K Ibrahim; D W Ellison; M Armitage; M Gawne-Cain; P D Lees
Journal:  Acta Neurochir (Wien)       Date:  2002-01       Impact factor: 2.216

2.  Lymphocytic panhypophysitis in a young man with involvement of the cavernous sinus and clivus.

Authors:  Ilkay Kartal; Sema Yarman; Refik Tanakol; Bilge Bilgic
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 3.  Lymphocytic hypophysitis with involvement of the cavernous sinus and hypothalamus.

Authors:  C E Nussbaum; S H Okawara; L S Jacobs
Journal:  Neurosurgery       Date:  1991-03       Impact factor: 4.654

Review 4.  Autoimmune hypophysitis.

Authors:  Patrizio Caturegli; Craig Newschaffer; Alessandro Olivi; Martin G Pomper; Peter C Burger; Noel R Rose
Journal:  Endocr Rev       Date:  2005-01-05       Impact factor: 19.871

5.  Cystic lymphocytic hypophysitis, visual field defects and hypopituitarism.

Authors:  J O Farah; M Rossi; P M Foy; I A MacFarlane
Journal:  Int J Clin Pract       Date:  1999-12       Impact factor: 2.503

6.  A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively.

Authors:  A Gutenberg; J Larsen; I Lupi; V Rohde; P Caturegli
Journal:  AJNR Am J Neuroradiol       Date:  2009-07-23       Impact factor: 3.825

7.  Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus.

Authors:  H Imura; K Nakao; A Shimatsu; Y Ogawa; T Sando; I Fujisawa; H Yamabe
Journal:  N Engl J Med       Date:  1993-09-02       Impact factor: 91.245

8.  A case of lymphocytic hypophysitis with massive fibrosis and the role of surgical intervention.

Authors:  H Nishioka; H Ito; T Miki; K Akada
Journal:  Surg Neurol       Date:  1994-07

9.  Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings.

Authors:  E Thodou; S L Asa; G Kontogeorgos; K Kovacs; E Horvath; S Ezzat
Journal:  J Clin Endocrinol Metab       Date:  1995-08       Impact factor: 5.958

Review 10.  Lymphocytic hypophysitis: disease spectrum and approach to diagnosis and therapy.

Authors:  Juan-Andres Rivera
Journal:  Pituitary       Date:  2006       Impact factor: 3.599

View more
  15 in total

1.  Pituitary Antibodies in an Adolescent with Secondary Adrenal Insufficiency and Turner Syndrome.

Authors:  Allison J Pollock; Tasa S Seibert; Cristiana Salvatori; Patrizio Caturegli; David B Allen
Journal:  Horm Res Paediatr       Date:  2016-06-30       Impact factor: 2.852

Review 2.  Pituitary autoimmune disease: nuances in clinical presentation.

Authors:  A Glezer; M D Bronstein
Journal:  Endocrine       Date:  2012-03-17       Impact factor: 3.633

3.  Outcomes of Initial Management Strategies in Patients With Autoimmune Lymphocytic Hypophysitis: A Systematic Review and Meta-analysis.

Authors:  Diane Donegan; Zeb Saeed; Danae A Delivanis; Mohammad Hassan Murad; Juergen Honegger; Felix Amereller; Seda Hanife Oguz; Dana Erickson; Irina Bancos
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

4.  Diffuse Basisphenoid Enhancement: Possible Differentiating Feature for Granulomatous Hypophysitis.

Authors:  I T Mark; C M Glastonbury
Journal:  AJNR Am J Neuroradiol       Date:  2022-08-25       Impact factor: 4.966

5.  Preoperative differentiation of hypophysitis and pituitary adenomas using a novel clinicoradiologic scoring system.

Authors:  Kyla Wright; Hyon Kim; Travis Hill; Matthew Lee; Cordelia Orillac; Nikita Mogar; Donato Pacione; Nidhi Agrawal
Journal:  Pituitary       Date:  2022-05-27       Impact factor: 3.599

6.  Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis.

Authors:  Tommaso Tartaglione; Sabrina Chiloiro; Maria Elena Laino; Antonella Giampietro; Simona Gaudino; Angelo Zoli; Antonio Bianchi; Alfredo Pontecorvi; Cesare Colosimo; Laura De Marinis
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

7.  MRI Findings of Immune Checkpoint Inhibitor-Induced Hypophysitis: Possible Association with Fibrosis.

Authors:  R Kurokawa; Y Ota; W Gonoi; A Hagiwara; M Kurokawa; H Mori; E Maeda; S Amemiya; Y Usui; N Sato; Y Nakata; T Moritani; O Abe
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-06       Impact factor: 3.825

8.  Autoimmune lymphocytic hypophysitis in association with autoimmune eye disease and sequential treatment with infliximab and rituximab.

Authors:  Chengyu Xu; Adriana Ricciuti; Patrizio Caturegli; C Dirk Keene; Atil Y Kargi
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

Review 9.  Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation.

Authors:  Sriram Gubbi; Fady Hannah-Shmouni; Joseph G Verbalis; Christian A Koch
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2019-12-12       Impact factor: 4.690

10.  Primary (autoimmune) hypophysitis: a single centre experience.

Authors:  Shruti Khare; Varsha S Jagtap; Sweta R Budyal; Rajeev Kasaliwal; Harshal R Kakade; Amol Bukan; Shilpa Sankhe; Anurag R Lila; Tushar Bandgar; Padmavathy S Menon; Nalini S Shah
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.